- Survey results from dialysis facilities in Australia and New Zealand indicate that environmental sustainability is not currently prioritized in facilities’ clinical practice, building design, or infrastructure and management systems.
- Results highlighted major deficiencies, and thereby opportunities for improvement.
Washington, DC (November 11, 2022) — Healthcare is a significant contributor to greenhouse gas emissions that impact climate change. In fact, if the global healthcare sector were a country, it would be the fifth-largest emitter on the planet. And within healthcare, dialysis programs contribute disproportionately, with high resource consumption and waste generation. A recent study published in CJASN examined the environmental sustainability practices of dialysis facilities, providing insights into where improvements could be made.
For the study, Benjamin Talbot, MBBS (The George Institute for Global Health) and his colleagues sent an online survey to the heads of all dialysis facilities in Australia and New Zealand between November 2019 and December 2020. Responses were received from 132 dialysis facilities, representing 33% (122/365) of dialysis services within Australia and New Zealand. Most responses were from public satellite facilities (40%), in-center dialysis facilities (25%) and co-located dialysis and home therapies facilities (21%).
Opportunities for improvement in environmental sustainability practices were identified in 3 domains:
- Culture—A minority of facilities reported having an environmental sustainability strategy in place (33%) or undertaking sustainability audits (20%). Only 7% reported the inclusion of environmental training in staff induction programs.
- Building design, infrastructure, energy use—Few facilities reported using renewable energy (14%), reclaiming reverse osmosis reject water (13%), or motion-sensor light-switches (44%).
- Operations—A minority of facilities reported having waste management education (36%), auditing waste generation (17%), or considering environmental sustainability in procurement decisions (25%).
“We have established a baseline of environmental sustainability practices in dialysis facilities in Australia and New Zealand, however, only 33% of dialysis facilities responded to the survey, which suggests that environmental sustainability is not a priority for most dialysis facilities. The responses to the survey regarding dialysis practices confirmed this further and demonstrate numerous areas where improvements can be made,” said Dr. Talbot. “As healthcare professionals, we have a duty to advocate for our patients and protect our planet. Dialysis is a life-saving treatment but it has a huge environmental cost, and we must all work together to find ways to reduce its impact.”
Additional study authors include Katherine Barraclough, MBBS, PhD, Matthew Sypek, MBBS, PhD, FRACP, Pedro Gois, MD, PhD, FRACP, FASN, Leila Arnold, MbChB, FRACP, Stephen McDonald, MBBS(Hons), PhD, FRACP, and John Knight, MBBS, MA, MBA, FRACP, FASN, GAICD.
Disclosures: B Talbot and J Knight are employees of Ellen Medical Devices developing the Affordable Dialysis program. K Barraclough has received research funding from Fresenius Medical Care. P Gois has received consultancy and honoraria fees from Alexion Pharmaceuticals. S McDonald has received research funding from Baxter Healthcare and Astellas Pharmaceuticals and has had advisory or leadership roles with Fresenius Kidney Care Australia. L Arnold reports employment and ownership interest in M and M Renal Limited.
The article, titled “A Survey of Environmental Sustainability Practices in Dialysis Facilities in Australia and New Zealand,” will appear online at http://cjasn.asnjournals.org/ on November 11, 2022, doi: 10.2215/CJN.08090722.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
About ASN Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 132 countries. For more information, visit www.asn-online.org and follow us on Facebook, Twitter, LinkedIn, and Instagram.
# # #